Key Clinical Message
Alopecia areata may develop in patients after COVID‐19 vaccination. Platelet‐rich plasma (PRP) has an outstanding anti‐inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids.
Abstract
A 34‐year‐old female with no systemic illness presented with non‐scarring hair loss after the second COVID‐19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double‐spin PRP therapy. Her hair recovered completely after six courses of PRP treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.